We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » CMS Opens Review to Determine Medicare Coverage of Provenge
CMS Opens Review to Determine Medicare Coverage of Provenge
July 1, 2010
The Centers for Medicare & Medicaid Services is beginning a national coverage analysis of Dendreon’s Provenge that could impact reimbursement of the prostate cancer treatment.